These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29105783)

  • 1. Clinical implications of mast cell involvement in allergic conjunctivitis.
    Elieh Ali Komi D; Rambasek T; Bielory L
    Allergy; 2018 Mar; 73(3):528-539. PubMed ID: 29105783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The central role of conjunctival mast cells in the pathogenesis of ocular allergy.
    Leonardi A
    Curr Allergy Asthma Rep; 2002 Jul; 2(4):325-31. PubMed ID: 12044269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conjunctival mast cells in ocular allergic disease.
    Graziano FM; Stahl JL; Cook EB; Barney NP
    Allergy Asthma Proc; 2001; 22(3):121-6. PubMed ID: 11424871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical role of IgE-dependent mast cell activation in a murine model of allergic conjunctivitis.
    Fukuda K; Ohbayashi M; Morohoshi K; Zhang L; Liu FT; Ono SJ
    J Allergy Clin Immunol; 2009 Oct; 124(4):827-33.e2. PubMed ID: 19660804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology of ocular allergy: the roles of conjunctival mast cells and epithelial cells.
    Stahl JL; Cook EB; Barney NP; Graziano FM
    Curr Allergy Asthma Rep; 2002 Jul; 2(4):332-9. PubMed ID: 12044270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seasonal allergic conjunctivitis is accompanied by increased mast cell numbers in the absence of leucocyte infiltration.
    Anderson DF; MacLeod JD; Baddeley SM; Bacon AS; McGill JI; Holgate ST; Roche WR
    Clin Exp Allergy; 1997 Sep; 27(9):1060-6. PubMed ID: 9678838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapracorat, a selective glucocorticoid receptor agonist, causes apoptosis of eosinophils infiltrating the conjunctiva in late-phase experimental ocular allergy.
    Baiula M; Bedini A; Baldi J; Cavet ME; Govoni P; Spampinato S
    Drug Des Devel Ther; 2014; 8():745-57. PubMed ID: 24959069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocking mast cell-mediated type I hypersensitivity in experimental allergic conjunctivitis by monocyte chemoattractant protein-1/CCR2.
    Tominaga T; Miyazaki D; Sasaki S; Mihara S; Komatsu N; Yakura K; Inoue Y
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5181-8. PubMed ID: 19553621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conjunctival mast cell as a mediator of eosinophilic response in ocular allergy.
    Miyazaki D; Tominaga T; Yakura K; Kuo CH; Komatsu N; Inoue Y; Ono SJ
    Mol Vis; 2008 Aug; 14():1525-32. PubMed ID: 18728750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bepotastine besilate, a highly selective histamine H(1) receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models.
    Kida T; Fujii A; Sakai O; Iemura M; Atsumi I; Wada T; Sakaki H
    Exp Eye Res; 2010 Jul; 91(1):85-91. PubMed ID: 20412793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunolocalization of cytokines to mast cells in normal and allergic conjunctiva.
    Macleod JD; Anderson DF; Baddeley SM; Holgate ST; McGill JI; Roche WR
    Clin Exp Allergy; 1997 Nov; 27(11):1328-34. PubMed ID: 9420138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The cellular players in allergy].
    Pisella PJ
    J Fr Ophtalmol; 2007 Mar; 30(3):283-7. PubMed ID: 17417155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of CCL7 in Type I Hypersensitivity Reactions in Murine Experimental Allergic Conjunctivitis.
    Kuo CH; Collins AM; Boettner DR; Yang Y; Ono SJ
    J Immunol; 2017 Jan; 198(2):645-656. PubMed ID: 27956527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of NFκB in the production of chemokines by rat and human conjunctival cells cultured under allergenic conditions.
    Sakai O; Tamada Y; Shearer TR; Azuma M
    Curr Eye Res; 2013 Aug; 38(8):825-34. PubMed ID: 23621293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olopatadine: a drug for allergic conjunctivitis targeting the mast cell.
    Leonardi A; Quintieri L
    Expert Opin Pharmacother; 2010 Apr; 11(6):969-81. PubMed ID: 20307221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent patents and emerging therapeutics in the treatment of allergic conjunctivitis.
    Mishra GP; Tamboli V; Jwala J; Mitra AK
    Recent Pat Inflamm Allergy Drug Discov; 2011 Jan; 5(1):26-36. PubMed ID: 21171952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergy and the eye.
    Leonardi A; Motterle L; Bortolotti M
    Clin Exp Immunol; 2008 Sep; 153 Suppl 1(Suppl 1):17-21. PubMed ID: 18721324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oleanolic acid controls allergic and inflammatory responses in experimental allergic conjunctivitis.
    Córdova C; Gutiérrez B; Martínez-García C; Martín R; Gallego-Muñoz P; Hernández M; Nieto ML
    PLoS One; 2014; 9(4):e91282. PubMed ID: 24699261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human ocular mast cells.
    Church MK; McGill JI
    Curr Opin Allergy Clin Immunol; 2002 Oct; 2(5):419-22. PubMed ID: 12582326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mast cell and eosinophil activation during early phase of grass pollen-induced ocular allergic reaction.
    Jedrzejczak-Czechowicz M; Lewandowska-Polak A; Jarzebska M; Kowalski ML
    Allergy Asthma Proc; 2011; 32(1):43-8. PubMed ID: 21262097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.